Perampanel oral soluble film and preparation method thereof
Through the combined use of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl acetate aqueous dispersion, the problem of insufficient solvent residue and stability in the perampanai oral dissolved film is solved, and solvent-free and rapid dissolution is achieved and high-stability perampanai oral-soluble membrane improve the convenience of drug transportation and use.
Patent Information
- Application Number
- CN202411325037.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-12-06
AI Technical Summary
There are problems in the preparation of the existing perampanai oral dissolution films, such as solvent residue, dissolution time limit, slow dissolution rate and insufficient stability. In addition, traditional methods require the use of organic solvents and high temperature conditions, which makes the product inconvenient to carry and transport.
The combination of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl acetate aqueous dispersion is used to quickly prepare solvent-free oral dissolving films at room temperature through standstill degassing process, avoiding the use of organic solvents, and A stable network structure is formed through a special spray drying process, which improves the stability and dissolution speed of the product.
The perampanai oral dissolving membrane without solvent residue, rapid dissolution and high stability is achieved, which shortens the preparation time, improves the safety of the product and patient compliance, and significantly improves the onset time of the drug.
Smart Images

Figure CN119074701A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of orodissolving films, and particularly relates to a perampanel orodissolving film and a preparation method thereof. Background Art
[0002] Perampanel is a white to slightly yellowish white powder, which is easily soluble in 1-methyl-2-pyrrolidone, slightly soluble in acetonitrile and acetone, slightly soluble in methanol, ethanol and ethyl acetate, very slightly soluble in 1-octanol and ether, and almost insoluble in heptane and water. Currently, the only perampanel preparations are tablets and oral suspensions. Tablets need to be taken with water, which is inconvenient for patients with epilepsy. Oral suspensions are inconvenient to carry and transport. The structure of perampanel contains cyano and amide bonds. The cyano group is easily oxidized in the presence of heat and strong oxidants, and the amide bond is easily hydrolyzed under heat, strong acid and strong alkali conditions. There is usually a long period of high temperature conditions during the preparation of the orodispersible film, and the risk of increased related substances in the perampanel orodispersible film is relatively high.
[0003] There is a document that discloses a perampanel oral dissolving film, which is mainly prepared with perampanel, polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, tartaric acid and film-forming material as main raw materials. The above-mentioned oral dissolving film, because polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer cannot be dissolved in water, needs to use 75% ethanol in the preparation process. The oral dissolving film production process needs to be dried in time, and it is difficult to remove ethanol in the drying process, and pores appear on the surface of the coating drying process due to ethanol volatilization. The oral dissolving film prepared by this method will inevitably have pores, as well as solvent residues, and the related substances are high, the dissolution time limit and dissolution rate are slow, and the sample stability also needs to be further improved.
[0004] Therefore, it is necessary to improve the existing perampanel oral film-dissolving preparation from the raw materials to overcome the above-mentioned disadvantages of the product, so as to obtain a product with no solution residue, low related substances, excellent dissolution time and dissolution rate, and stability. Summary of the invention
[0005] In order to solve the above technical problems, the present invention improves the raw materials and uses a polyvinyl alcohol-polyethylene glycol copolymer and a polyvinyl alcohol mixture (Kollicoat ® Protect), polyvinyl acetate aqueous dispersion (Kollicoat ® SR30D), without the use of defoaming agent, can achieve static degassing process, can be quickly degassed within 2 hours, not only significantly shorten the preparation time, avoid the use of organic solvents, effectively control the product's impurities and residual solvent levels. According to the test, the total impurity is less than 0.05%, there is no residual solvent, and the safety of the sample is improved. At the same time, polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture (Kollicoat ®Protect), polyvinyl acetate aqueous dispersion (Kollicoat ® The combined use of SR 30D) also improves sample stability.
[0006] The perampanel orosoluble film comprises the following raw materials in parts by weight: 1-10 parts perampanel, 50-80 parts of a mixture of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol, 10-40 parts of a polyvinyl acetate aqueous dispersion, 2-5 parts of glycerol, 2-5 parts of citric acid, 0.2-0.8 parts of orange flavor, 0.2-0.8 parts of tartrazine, and 0.5-5 parts of sucralose, and further comprises: purified water, wherein the purified water is used in an amount such that the solid content is 20%-40%.
[0007] In the present invention, the polyvinyl alcohol-polyethylene glycol copolymer, polyvinyl alcohol mixture, and polyvinyl acetate aqueous dispersion used are all produced by BASF SE.
[0008] The polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture are composed of 55-65% polyvinyl alcohol-polyethylene glycol graft copolymer, 35-45% polyvinyl alcohol and 0.1-0.3% silicon dioxide as a flow aid. It is a white to off-white, free-flowing powder. Compared with similar products, its performance characteristics are that it dissolves quickly in water, its aqueous solution has a lower viscosity and is easy to prepare, and an aqueous glue can be prepared at room temperature of 10-30°C, and a film can be formed quickly at 60°C, with excellent film-forming properties and plasticity. After film formation, it has good moisture-proof and oxygen-barrier properties. In the present invention, it is used as a film-forming material, and the film is formed quickly after the liquid is prepared at room temperature and dried immediately.
[0009] Polyvinyl acetate aqueous dispersion is an aqueous dispersion with a solid content of 30%. It has a faint characteristic odor and a milky white appearance. The dispersion is composed of about 27% polyvinyl acetate, 2.7% povidone and 0.3% sodium lauryl sulfate. The product can be miscible with water in any proportion while maintaining its milky white appearance, and has low viscosity, high plasticity and flexibility. In the present invention, it is also used as a film-forming material. Because polyvinyl acetate is insoluble in water, it exists in the form of tiny particles that are invisible to the naked eye in the film. After encountering water, the oral dissolving film can quickly form holes, accelerating the dissolution of the oral dissolving film.
[0010] The polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture are used in combination with the polyvinyl acetate aqueous dispersion and applied as film-forming materials in the present invention. The principle of their joint action is that both contain a large number of hydroxyl groups and oxygen atoms, hydrogen bonds are formed between molecules, and a stable network microstructure is constructed after uniform dispersion and coating. The polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture adopt a special spray drying process, and the polymers are embedded in each other and cannot be separated. The powder has good fluidity and can be quickly dissolved in water. The polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture are dissolved in water during the liquid preparation process, and the polyvinyl acetate aqueous dispersion and perampanel are dispersed in the polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture aqueous solution in the form of tiny suspended particles during the liquid preparation process. Therefore, the viscosity of the prepared glue is only 3000~4000mPa·s, and the film forming temperature is 30~50℃, which is very easy to form a film. The glue rapidly forms a film during the coating and drying process, and together forms a stable, highly water-soluble, and quickly dissolving network structure, in which perampanel is wrapped.
[0011] Therefore, the two can be prepared without organic solvents, quickly prepared at room temperature, and dried to form films instantly, and together form a stable network structure to encapsulate perampanel, have waterproof and anti-oxidant effects, and improve the stability of perampanel. The presence of polyvinyl acetate particles allows the orosoluble film to dissolve quickly when it comes into contact with water.
[0012] In summary, the combined use of the polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture with the polyvinyl acetate aqueous dispersion not only improves the stability of the perampanel orodispersible film, but also achieves rapid dissolution of the orodispersible film.
[0013] Although there are other similar film-forming materials, for example, there are literature disclosures of polyethylene caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers, and the polyethylene glycol and polyvinyl alcohol graft copolymer Kollicoat tested in the present invention. ® IR, ethyl acrylate, methyl methacrylate (2:1) copolymer Eudragit ® NE30D, polyvinyl alcohol, etc., but the inventors found that the combination within this range of proportions in the present invention has the best effect compared with the combination of other film-forming materials. This shows that the orally dissolving film products produced by combining the same film-forming materials have a long dissolution time and low solubility, and the effect is not ideal.
[0014] The particle size d90 of perampanel is below 10 microns.
[0015] Preferably, the above-mentioned perampanel orosoluble film comprises the following raw materials in parts by weight: 8 parts perampanel, 60 parts of a mixture of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol, 20 parts of a polyvinyl acetate aqueous dispersion, 5 parts of glycerol, 5 parts of citric acid, 0.5 parts of orange flavor, 0.5 parts of tartrazine, and 1 part of sucralose, and also comprises purified water, wherein the amount of purified water is such that the solid content is 30%.
[0016] Preferably, the method for preparing the above-mentioned perampanel orosoluble film comprises the following steps: S1: prepare the raw materials according to the ratio in claim 1, add purified water and glycerin into an emulsification tank, and emulsify; S2: Add citric acid, sucralose, polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture, polyvinyl acetate aqueous dispersion, perampanel, orange flavor, and tartrazine to the materials in S1 and stir; S3: Turn off stirring and emulsification, let stand, degas, and obtain glue solution; S4: The degassed glue solution is applied using a film-making machine and dried to obtain an orally dissolving film.
[0017] Preferably, in S1, during emulsification, the rotation speed is controlled to 2000 rpm±200 rpm.
[0018] In S2, the stirring speed is 30 rpm ± 5 rpm, and the stirring time is 30 min.
[0019] Let stand in S3 for 1.5~2.5h.
[0020] In S4, when a film making machine is used for coating, the selected base film material is a polyester film of 75 μm ± 5 μm, the coating speed is 0.8 m / min, the drying temperature is 60~80°C, and the drying air frequency is 20~40HZ.
[0021] The process further comprises S5: using a film packaging machine to cut and inner-package the orally dissolving film dried in S4, wherein the inner-package material is a double aluminum composite film.
[0022] The beneficial effects of the present invention are: (1) Control of product impurities and residual solvents The present invention focuses on improving the raw material formula and using a polyvinyl alcohol-polyethylene glycol copolymer and a polyvinyl alcohol mixture (Kollicoat ® Protect), polyvinyl acetate aqueous dispersion (Kollicoat ® Compared with the existing technology, one of the biggest features of SR 30D is that it does not use ethanol. By avoiding the use of organic solvent ethanol, the impurity and residual solvent levels of the product are effectively controlled, making the total impurity less than 0.05% and no residual solvent, which further improves the product stability; (2) Improved sample stability After 6 months of acceleration, the content of related substances and the dissolution time are basically the same as those of 0 months; see the data comparison in the experimental example in the specific implementation method for details; (3) Rapid dissolution While adjusting the raw material formula, the particle size d90 of perampanel is controlled below 10 microns, and the drug loading is controlled within 10%. Without adding surfactants, disintegrants and defoamers, the dissolution time and solubility of perampanel are greatly improved, avoiding the appearance of obvious particles, bubbles and oil droplets. The prepared perampanel oral dissolving film can be quickly dissolved within 15 seconds, and the solubility is more than 85% within 10 minutes. Due to the above characteristics of the product, the patient's compliance is significantly improved and the onset time of the drug is shortened.
[0023] (4) Scalable application to achieve large-scale production Without adding surfactants, the glue solution was quickly prepared in 0.5 hours and degassed in 2 hours. Moreover, the glue solution was dried immediately after coating, and 100,000 pieces of orodispersible film products could be prepared in 8 hours. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is an electron microscope image of the product in Example 1; Figure 2 This is an electron microscope image of the product in Comparative Example 1; Figure 3 This is the electron microscope image of the product in Comparative Example 2; Figure 4 This is the electron microscope image of the product in Comparative Example 3; Figure 5 This is an electron microscope image of the product in Comparative Example 4; Figure 6 This is the electron microscope image of the product in Comparative Example 5. DETAILED DESCRIPTION
[0025] In order to enable those skilled in the art to better understand the present invention, the present invention is further described in conjunction with specific implementation methods.
[0026] The raw materials in the present invention are purchased from the following manufacturers: Low viscosity polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture (hereinafter referred to as: Kollicoat ® Protect), the viscosity of its 20% aqueous solution is 240mPa·s, and the manufacturer is BASE SE. Among them, polyvinyl alcohol-polyethylene glycol copolymer: polyvinyl alcohol = 4:1 (mass ratio); Polyvinyl acetate aqueous dispersion (hereinafter referred to as: Kollicoat ®SR 30D), manufacturer: BASE SE.
[0027] Other raw materials are common commercial products and will not be described in detail here.
[0028] Example 1 Take the raw materials according to the weight ratio in Table 1 below: prescription Proportion Perampanel 8% <![CDATA[Kollicoat ® Protect]]> 60% <![CDATA[Kollicoat ® SR 30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The specific method for preparing the perampanel orosoluble film is as follows: S1: Take the raw materials according to the weight ratio in Table 1; S2: At room temperature, add purified water and glycerin into the emulsification tank, start emulsification, and rotate at 2000rpm±200rpm; S3: Add citric acid, sucralose, Kollicoat® Protect, Kollicoat® SR 30D, perampanel, orange flavor, and tartrazine at room temperature; start stirring at a speed of 30 rpm ± 5 rpm for 30 min; S4: Turn off stirring and emulsification, let stand for 2 hours, degas, and obtain glue solution; S5: Use a film-making machine to coat and dry the degassed adhesive solution. The base film material is a polyester film of 75μm±5μm, the coating speed is 0.8m / min, the drying temperature is 60~80℃, and the drying air frequency is 20~40HZ.
[0029] S6: The dried orally dissolving film is cut and inner-packed using a film packaging machine, and the inner packaging material is a double aluminum composite film.
[0030] The perampanel orosoluble film prepared by the above process has the following characteristics: (1) High safety and excellent stability The liquid preparation process was carried out at room temperature (10-30°C), water was used as the solvent, and a mixture of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol (Kollicoat ® Protect), polyvinyl acetate aqueous dispersion (Kollicoat ® SR30D), without the use of defoaming agent, realizes the static degassing process and can quickly degas within 2 hours.
[0031] This formulation process significantly shortens the preparation time, avoids the use of organic solvents, and effectively controls the impurity and residual solvent levels of the product. The total impurity is less than 0.05%, there is no residual solvent, and the sample stability is improved.
[0032] (2) Good effectiveness Use a low viscosity polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture (Kollicoat ®Protect) and polyvinyl acetate aqueous dispersion (Kollicoat ® SR 30D), the particle size d90 of perampanel is controlled below 10 microns, and the drug loading is controlled within 10%. Without adding surfactants, disintegrants and defoaming agents, the dissolution time and solubility of perampanel are greatly improved, and the appearance of obvious particles, bubbles and oil droplets is avoided. The perampanel oral dissolving film prepared by the prescription process of this product can be quickly dissolved within 15 seconds, and the solubility exceeds 85% within 10 minutes, which significantly improves patient compliance and shortens the onset time of the drug.
[0033] Example 2-6 is the same as the preparation method of Example 1, except that the amount of raw materials is changed. The specific material list is shown in Table 2: Table 2 The ratio of raw materials used in Examples 1-6 prescription Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Perampanel 8% 8% 8% 1.5% 1.5% 3.4% <![CDATA[Kollicoat ® Protect]]> 60% 60% 60% 50% 80% 70% <![CDATA[Kollicoat ® SR30D (based on solid content)]]> 20% 20% 20% 40% 10% 10% glycerin 5% 5% 5% 2% 5% 5% Citric acid 5% 5% 5% 5% 2% 5% Orange flavor 0.50% 0.50% 0.50% 0.2% 0.8% 0.8 Lemon Yellow 0.50% 0.50% 0.50% 0.8% 0.2% 0.8 Sucralose 1.00% 1.00% 1.00% 0.5% 0.5% 5% Purified water Add to 30% solid content of glue Add to the glue liquid solid content of 20% Add to 40% solid content of glue Add to 30% solid content of glue Add to 30% solid content of glue Add to 30% solid content of glue Comparative Example 1 Table 3 The amount of each raw material in Comparative Example 1 prescription Weight ratio Perampanel 8.70% Hydroxypropyl methylcellulose E5 60.87% Hydroxypropyl methylcellulose K15M 12.17% <![CDATA[Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer Soluplus ® > 1.74% tartaric acid 0.52% Triethyl citrate 14.61% Red Iron Oxide 0.09% Peach flavor 0.43% High fructose corn syrup 0.87% The process corresponding to Comparative Example 1 is as follows: S1: Take 75% ethanol by volume, add the prescribed amount of tartaric acid, stir and disperse evenly, add polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer Soluplus® and stir until dissolved, then disperse and dissolve the prescribed amount of perampanel in Table 3 in the above solution while slowly stirring to obtain a drug-containing solution; S2 weighs the prescribed amount of hypromellose E5 and hypromellose K15M, slowly adds them to the above drug-containing solution while stirring, and adds triethyl citrate, peach flavor, red iron oxide, and high fructose syrup and stirs evenly to obtain a drug-containing matrix solution with a viscosity in the range of 5000-10000 mpa·s; S3: Degas the drug-containing matrix solution by centrifugation, let it stand, and then use a coating machine to apply the drug-containing matrix solution to a dimethyl silicone oil-coated polyester film for patch preparation, dry it at about 60°C, and roll it up. The coating thickness is controlled within the range of 400-500 μm, and then it is cut and packaged.
[0034] Comparative Example 2 Table 4 The dosage ratio of each raw material in Comparative Example 2 prescription Dosage (mg / tablet) Perampanel 4 Hydroxypropyl methylcellulose 14.86 Hydroxypropylcellulose 4 Sorbitol 3.46 Poloxamer 188 1.2 Sucralose 0.20 Citric acid 0.20 Purified water 128 In Comparative Example 2, the sample preparation method is as follows: (1) Dissolve poloxamer 188 and citric acid in purified water; (2) Add perampanel under stirring and disperse using a disperser at a speed of 10,000 rpm to obtain a uniform suspension; (3) Add trichlorosucrose, sorbitol, hypromellose and hydroxypropyl cellulose to the suspension obtained in step (2) according to the ratio in Table 4, and stir to form a uniform liquid; (4) After vacuum defoaming, the drug solution is evenly coated on the PET release film and dried. The dried sample is cut into a certain size (specification: 4 mg, area: 2.0×3.3 cm) and packaged with polyester composite film, or aluminum and polyethylene composite film.
[0035] Comparative Example 3 Table 5 The dosage ratio of each raw material in Comparative Example 3 prescription Dosage (mg / tablet) Perampanel (jet mill, D90 4.5μm) 2 Hydroxypropylcellulose 17.6 Titanium Dioxide 0.4 Purified water 45 The preparation method of the sample in Comparative Example 3 is as follows: (1) crushing the perampanel API by a jet mill; (2) Mix the raw materials according to the ratio in Table 5; (3) Homogenizing in aqueous solution at a uniform speed of 1500 rpm for 3 min; (4) Apply the suspension on the substrate and dry it to form a film. After the film is completely dry, gently tear off the film, cut it according to specifications, and package it.
[0036] Comparative Example 4 Table 6 The dosage ratio of each raw material in Comparative Example 4 prescription Dosage (g) Perampanel 1 Hydroxypropyl methylcellulose E50 5 Hydroxyethyl Cellulose 250G 1 Maltodextrin 5 glycerin 2 Sucralose 0.15 Purified water Add to 84 Preparation method: Take 30g of purified water, heat it to above 85°C, add the prescribed amount of perampanel, film-forming agent, maltodextrin, glycerol and sucralose, add water to 84g, stir and mix to obtain a drug-containing slurry; transfer the obtained drug-containing slurry to a vacuum degassing cup, and use a vacuum degassing mixer to degas; adjust the coating knife height to 600μm, apply the obtained degassed slurry on an inert carrier material, and place it in a 60°C oven to dry for 40min to form a film.
[0037] Comparative Example 5 Take each raw material according to the weight ratio in Table 7 below: Table 7 The dosage ratio of each raw material in Comparative Example 5 prescription Proportion Perampanel 8% <![CDATA[Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer Soluplus ® > 60% <![CDATA[Kollicoat ® SR 30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The steps are the same as in Example 1.
[0038] Comparative Example 6 Take each raw material according to the weight ratio in Table 8 below: Table 8 The dosage ratio of each raw material in Comparative Example 6 prescription Proportion Perampanel 8% <![CDATA[Polyethylene glycol and polyvinyl alcohol graft copolymer Kollicoat ® IR]]> 60% <![CDATA[Kollicoat ® SR 30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The steps are the same as in Example 1.
[0039] Comparative Example 7 Take each raw material according to the weight ratio shown in Table 9 below: Table 9 The dosage ratio of each raw material in Comparative Example 7 prescription Proportion Perampanel 8% <![CDATA[Kollicoat ® Protect]]> 60% <![CDATA[Ethyl acrylate, methyl methacrylate (2:1) copolymer Eudragit ® NE30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The steps are the same as in Example 1.
[0040] Comparative Example 8 Compared with Example 1, the types of main raw materials are adjusted, as shown in the following table: Table 10 The dosage ratio of each raw material in Comparative Example 8 prescription Proportion Perampanel 8% <![CDATA[Polyethylene glycol and polyvinyl alcohol graft copolymer Kollicoat ® IR]]> 42% Polyvinyl alcohol 18% <![CDATA[Kollicoat ® SR 30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The preparation method is the same as that of Example 1.
[0041] Comparative Example 9 Compared with Example 1, the dosage of the main raw materials was adjusted, as shown in the following table: Table 11 The dosage ratio of each raw material in Comparative Example 9 prescription Proportion Perampanel 8% <![CDATA[Polyethylene glycol and polyvinyl alcohol graft copolymer Kollicoat ® IR]]> 50% Polyvinyl alcohol 50% <![CDATA[Kollicoat ® SR 30D]]> 20% (based on solid content) glycerin 5% Citric acid 5% Orange flavor 0.50% Lemon Yellow 0.50% Sucralose 1.00% Purified water Add to solid content 30% The preparation method is the same as that of Example 1.
[0042] Test Example 1 The samples in Examples 1-6 and Comparative Examples 1-9 were taken, their appearance was observed, and the dissolution rate (%) in 0.1M hydrochloric acid for 10 min, the residual solvent, the total impurities of related substances after preparation, and the dissolution time were tested; as well as the total impurities of related substances and the dissolution time after 6 months of acceleration. The specific results are shown in the following table: Table 12 Comparison of sample test results in Examples 1-6 and Comparative Examples 1-9
[0043] The samples of Examples 1-6 have no bubbles or white spots, and have a good appearance. There is no residual solvent, and the total impurities of related substances are less than 0.05%. They can be quickly dissolved within 15 seconds, and the solubility exceeds 85% within 10 minutes. In an environment of 40℃±2℃ and 75%±5%RH for 6 months, the increase in the total impurities of related substances is less than 0.05%, and the melting time is within 15 seconds, with good stability.
[0044] The sample prepared in Comparative Example 1 has small pores in appearance, high residual solvent, total impurities of related substances exceeding 0.05%, dissolution time exceeding 15s, and dissolution rate of less than 85% in 10min. The total impurities of related substances increased by 0.13% after 6 months of acceleration.
[0045] The sample prepared in Comparative Example 2 has small pores in appearance, the total impurities of related substances exceed 0.05%, and the melting time exceeds 15s. The total impurities of related substances increase by 0.09% after 6 months of acceleration.
[0046] The sample prepared in Comparative Example 3 had white spots on the surface, the total impurities of related substances exceeded 0.05%, the dissolution time exceeded 30s, and the dissolution rate was less than 85% in 10min. The total impurities of related substances increased by 0.11% after 6 months of acceleration.
[0047] The sample prepared in Comparative Example 4 had white spots on the surface, the total impurities of related substances exceeded 0.05%, the dissolution time exceeded 60s, and the dissolution rate was less than 85% in 10min. The total impurities of related substances increased by 0.13% after 6 months of acceleration.
[0048] In Comparative Example 5, a polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer Soluplus was used. ® and Kollicoat ® SR 30D is used as a film-forming material. After testing, the product appearance has small pores and white spots, the total impurities of related substances exceed 0.05%, the melting time exceeds 15s, and the solubility in 10min is less than 85%.
[0049] In Comparative Example 6, the polyethylene glycol and polyvinyl alcohol graft copolymer Kollicoat ® IR and Kollicoat ® SR30D was used as the film-forming material. The results showed that the product had no bubbles or white spots, had a good appearance, had a melting time of more than 15s, and had a dissolution rate of less than 85% in 10min.
[0050] In Comparative Example 7, Kollicoat ® Protect and ethyl acrylate, methyl methacrylate (2:1) copolymer Eudragit ® NE30D was used as the film-forming material. The results showed that the product had no bubbles or white spots, had a good appearance, had a melting time of more than 90s, and had a dissolution rate of less than 70% in 10min.
[0051] It can be seen from comparative examples 5-7 that when the polyvinyl alcohol-polyethylene glycol copolymer and the polyvinyl alcohol mixture are used in combination with the polyvinyl acetate aqueous dispersion, the sample has no bubbles, no white spots, and a good appearance; no residual solvent, and the total impurities of related substances are less than 0.05%; it can be quickly dissolved within 15 seconds, and the solubility exceeds 85% within 10 minutes. In an environment of 40℃±2℃, 75%±5%RH for 6 months, the total impurities of related substances increased by less than 0.05%, and the dissolution time was within 15 seconds, with good stability. If any of these two materials is replaced, the effect is not as good as the present invention.
[0052] In Comparative Examples 8 and 9, the amount of polyethylene glycol and polyvinyl alcohol graft copolymer and polyvinyl alcohol was adjusted. The samples had no bubbles or white spots and good appearance. The residual solvent (ethanol content) was not detected, and the total impurities of related substances were less than 0.05%. The melting time exceeded 15 seconds, and the solubility was less than 90% in 10 minutes. If the ratio of these two materials is adjusted beyond Kollicoat ® Protect's ratio range, its effect is not as good as the present invention.
Claims
1. Perampanel orosoluble film, characterized in that: The invention mainly comprises the following raw materials in parts by weight: 1-10 parts of perampanel, 50-80 parts of a mixture of a polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol, and 10-40 parts of a polyvinyl acetate aqueous dispersion.
2. The perampanel orosoluble film according to claim 1, characterized in that The following raw materials are also included in parts by weight: Glycerin 2~5, citric acid 2~5, orange flavor 0.2~0.8, tartrazine 0.2~0.8, sucralose 0.5~5, purified water, the amount of purified water is up to the solid content of 20%~40%.
3. The perampanel orosoluble film according to claim 1, characterized in that The particle size d90 of perampanel is below 10 microns.
4. The perampanel orosoluble film according to claim 1, characterized in that The invention comprises the following raw materials in parts by weight: 8 parts of perampanel, 60 parts of a mixture of polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol, 20 parts of a polyvinyl acetate aqueous dispersion, 5 parts of glycerol, 5 parts of citric acid, 0.5 parts of orange flavor, 0.5 parts of tartrazine, 1 part of sucralose, and the balance is purified water, and the amount of purified water used is such that the solid content reaches 30%.
5. The method for preparing the perampanel orosoluble film according to claim 1, comprising the following steps: S1: prepare the raw materials according to the ratio in claim 1, add purified water and glycerin into an emulsification tank, and emulsify; S2: Add citric acid, sucralose, polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture, polyvinyl acetate aqueous dispersion, perampanel, orange flavor, and tartrazine to the materials in S1 and stir; S3: Turn off stirring and emulsification, let stand, degas, and obtain glue solution; S4: The degassed glue solution is applied using a film-making machine and dried to obtain an orally dissolving film.
6. The method for preparing the perampanel orosoluble film according to claim 5, characterized in that: In S1, during emulsification, the speed was controlled to be 2000 rpm ± 200 rpm; In S2, the stirring speed is 30 rpm ± 5 rpm, and the stirring time is 30 min.
7. The method for preparing the perampanel orosoluble film according to claim 5, characterized in that: Let stand in S3 for 1.5h~2.5h.
8. The method for preparing the perampanel orosoluble film according to claim 5, characterized in that: In S4, when a film making machine is used for coating, the selected base film material is a polyester film of 75μm±5μm, the coating speed is 0.8m / min, the drying temperature is 60℃~80℃, and the drying air frequency is 20HZ~40HZ.
9. The method for preparing the perampanel orosoluble film according to claim 5, characterized in that: The process further comprises S5: using a film packaging machine to cut and inner-package the orally dissolving film dried in S4, wherein the inner-package material is a double aluminum composite film.
10. Use of a polyvinyl alcohol-polyethylene glycol copolymer, a polyvinyl alcohol mixture and a polyvinyl acetate aqueous dispersion in a perampanel orosoluble film, characterized in that: The weight proportions of perampanel, polyvinyl alcohol-polyethylene glycol copolymer and polyvinyl alcohol mixture, and polyvinyl acetate aqueous dispersion are: (6-10): (50-80): (10-40) respectively.
Citation Information
Patent Citations
Fycompa oral dissolving film agent and preparation method thereof
CN109106696A
Perampanel electrospun fiber oral instant film agent and preparation method thereof
CN114557982A
Perampanel oral soluble film agent
CN116617193A
Perampanel oral soluble film and preparation method thereof
CN117398365A
Oromucosal delivery system containing remimazolam
WO2024126745A1
